PER-055-02已完成未知
COMPARATIVE, MULTICENTER, DOUBLE-BLIND, RANDOMIZED STUDY OF RIFAXIMIN VS CYPROFLOXACIN (CIPRO®) IN THE TREATMENT OF DISEASE DIAPEREA CAUSED BY ENTEROPATHOGENIC ORGANISMS
IVERSIDAD PERUANA CAYETANO HEREDIA,0 个研究点目标入组 0 人开始时间: 2002年8月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of male or female sex of 18 years of age or
- •A minimum of three stools not formed within 24 hours prior to randomization.
- •Acute diarrhea and presence of at least one of the signs or symptoms of enteric infection present for a period not exceeding 96 hours.
排除标准
- •Acute diarrhea for more than 96 hours.
- •Moderate or severe dehydration.
- •Temperature <39.0 ° C (<102.2®F).
- •White blood cell count> 20,000 or bandemia> 20%
- •Presence of systemic toxicity that suggests a disease
- •Positive detection of E. histolytic trophozoites.
研究者
相似试验
已完成
不适用
COMPARATIVE, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-MASKED STUDY OF AZITROMYCIN SR VERSUS LEVOFLOXACIN FOR THE TREATMENT OF PNEUMONIA ACQUIRED IN THE MILD TO MODERATE COMMUNITY IN ADULTS-J159 Bacterial pneumonia, unspecifiedBacterial pneumonia, unspecifiedJ159PER-023-03PFIZER S.A.,
进行中（未招募）
不适用
MULTICENTER, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE WITH THE REFERENCE PRODUCT CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE THERAPY WITH THE COMBINATION OF BENZOYL PEROXIDE-ERYTHROMYCIN/VERISFIELD, GEL, (5+3)% W/W FOR THE TOPICAL TREATMENT OF ACNE VULGARISEUCTR2009-016240-40-GRVERISFIELD (UK) LTD, GREEK BRANCH
进行中（未招募）
不适用
MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE WITH THE REFERENCE PRODUCT CLINICAL STUDY TO DEMONSTRATE THE SAFETY AND EFFICACY OF THE THERAPY WITH THE COMBINATION ERYTHROMYCIN-ISOTRETINOIN/VERISFIELD, GEL, (2.0+0.05)% W/W FOR THE TOPICAL TREATMENT OF MILD TO MODERATE ACNEEUCTR2009-016241-25-GRVERISFIELD (UK) LTD, GREEK BRANCH
进行中（未招募）
不适用
MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE STUDY WITH THE REFERENCE PRODUCTS, FOR ASSESSMENT OF THERAPEUTIC SUPERIORITY OF THE COMBINATION CLINDAMYCIN-TRETINOIN/VERISFIELD, GEL, (1.0+0.025)%, (VERSUS THE MONOTHERAPY WITH CLINDAMYCIN OR TRETINOIN) FOR THE TOPICAL TREATMENT OF ACNEACNE (ACNE VULGARIS)EUCTR2009-017201-11-GRVERISFIELD (UK) LTD, GREEK BRANCH
已完成
不适用
RANDOMIZED, DOUBLE-BLIND, MULTICENTRIC COMPARATIVE STUDY, PHASE III, WITH TWO COURSES OF DIFFERENT THERAPY WITH BMS-284756 ORAL VS AMOXICILLINE / ORAL CLAVULANATE IN THE TREATMENT OF ACUTE SINUSITISPER-054-01BRISTOL MYERS SQUIBB PERU S.A.,